News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News
The top business, scientific and regulatory news from the pharmaceutical and biotechnology industries.

Pandemic Vaccine Facility Dedicated in Texas

September 19, 2014

Texas A&M dedicates national pandemic influenza vaccine manufacturing facility.

GSK Fined in China Bribery Scandal

September 19, 2014

GSK is found guilty of offering bribes to doctors and is find $489 million.

Guideline Delineates How to Implement GS1 Standards to Support DSCSA

September 19, 2014

GS1 publishes a healthcare industry guideline describing how to implement GS1 standards to support requirements of the 2013 US Drug Supply Chain Security Act.

GPhA Supports Restricted Access Bill

September 18, 2014

GPhA throws its support behind a bill to prohibit companies from using REMS practices to deter competition.

Baxter Names New Biopharmaceutical Company Baxalta

September 17, 2014

Baxter announced that its new biopharmaceutical company will be named Baxalta when the company separates into two publicly traded companies in mid-2015.

Baxter Initiates Voluntary Recall of Potassium Chloride Injection

September 17, 2014

Baxter International initiated a US voluntary recall of one lot of potassium chloride injection due to mislabeled shipping carton.

FDA Approves AstraZeneca's Movantik

September 16, 2014

AstraZeneca's Movantik was approved by FDA in the treatment of opioid-induced constipation.

Generic Pharmaceutical Association Reports Record Cost Savings

September 16, 2014

A GPhA report says generic drugs saved the US health system $239 billion in 2013.

Thomson Reuters Projects Pharma Sales Will Reach $1 Trillion in 2014

September 16, 2014

The Reuters Annual Pharmaceutical Factbook reveals positive outlook for pharmaceutical industry and key insights into current trends.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here